Cargando…
Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent
The coronavirus disease 2019 (COVID-19) outbreak in North, Central, and South America has become the epicenter of the current pandemic. We have suggested previously that the infection rate of this virus might be lower in people living at high altitude (over 2,500 m) compared to that in the lowlands....
Autores principales: | Arias-Reyes, Christian, Carvajal-Rodriguez, Favio, Poma-Machicao, Liliana, Aliaga-Raduán, Fernanda, Marques, Danuzia A., Zubieta-DeUrioste, Natalia, Accinelli, Roberto Alfonso, Schneider-Gasser, Edith M., Zubieta-Calleja, Gustavo, Dutschmann, Mathias, Soliz, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006995/ https://www.ncbi.nlm.nih.gov/pubmed/33780470 http://dx.doi.org/10.1371/journal.pone.0237294 |
Ejemplares similares
-
Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?
por: Arias-Reyes, Christian, et al.
Publicado: (2020) -
Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020) -
The Oxygen Transport Triad in High-Altitude Pulmonary Edema: A Perspective from the High Andes
por: Zubieta-Calleja, Gustavo, et al.
Publicado: (2021) -
Oxygen therapy limiting peripheral oxygen saturation to 89-93% is associated with a better survival prognosis for critically ill COVID-19 patients at high altitudes
por: Viruez-Soto, Antonio, et al.
Publicado: (2022) -
Pneumolysis and “Silent Hypoxemia” in COVID-19
por: Zubieta-Calleja, Gustavo, et al.
Publicado: (2020)